Prevalence of mixed dyslipidemia among Australian patients undergoing lipid-modifying therapy

著者: Colquhoun, David, Chirovsky, Diana, Sazonov, Valsilisa, Cui, Yadong A, Ambegaonkar, Baishali
出版事項 2013

Assessing the Comparability of Paper and Electronic Versions of the EORTC QOL Module for Head and Neck Cancer: A Qualitative Study

著者: Norquist, Josephine, Chirovsky, Diana, Munshi, Teja, Tolley, Chloe, Panter, Charlotte, Gater, Adam
出版年 JMIR Cancer (2017)

Cost-Effectiveness of Pembrolizumab Regimens for the First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Argentina

著者: Wurcel, Victoria, Chirovsky, Diana, Borse, Rebekah, Altuna, Juan Ignacio, Carabajal, Fernando, Gandhi, Jyotika
出版年 Adv Ther (2021)

Utilization patterns of extended-release niacin in Canada: Analysis of an administrative claims database

著者: Dorais, Marc, Chirovsky, Diana, Ambegaonkar, Baishali, Sazonov, Vasilisa, Davies, Glenn, Grant, Susan, LeLorier, Jacques
出版事項 2010

Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States

著者: Priyadarshini, Masoom, Prabhu, Vimalanand S., Snedecor, Sonya J., Corman, Shelby, Kuter, Barbara J., Nwankwo, Chizoba, Chirovsky, Diana, Myers, Evan
出版年 Front Public Health (2021)

Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient’s perspectiv...

著者: Hirji, Ishan, Gupta, Shaloo, Goren, Amir, Chirovsky, Diana R, Moadel, Alyson B, Olavarria, Eduardo, Victor, Timothy W, Davis, Catherine C
出版事項 2013

Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040

著者: Harrington, Kevin J, Soulières, Denis, Le Tourneau, Christophe, Dinis, Jose, Licitra, Lisa F, Ahn, Myung-Ju, Soria, Ainara, Machiels, Jean-Pascal H, Mach, Nicolas, Mehra, Ranee, Burtness, Barbara, Ellison, Misoo C, Cheng, Jonathan D, Chirovsky, Diana Romana, Swaby, Ramona F, Cohen, Ezra E W
出版年 J Natl Cancer Inst (2020)